Taurine and metabolic
What 2 graded rows on taurine agree on for metabolic, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Taurine page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Taurine page, with its PubMed record.
Your question
Taurine and metabolic
2 rows · 1,233 peopleThey agree: both rows found an improvement.
- BGrade B× 1
- CGrade C× 1
- Rows
- 2
- Trials
- 2
- At least: a review without a trial count
- People
- 1,233
- Pooled reviews may count some twice
What the rows share
From the rowsThe best-graded row, grade B, is a meta-analysis of 1,024 people (2024) and found an improvement.
The rows run from 209 to 1,024 people, published from 2022 to 2024: 2 pooled reviews and 0 single studies.
The rows
2 improved- BGrade BBlood pressure, fasting glucose and triglycerides · Improved
Meta-analysis · n 1,024 · 2024 · Participants in 25 randomized controlled trials
0.5 to 6 g/day · 5 to 365 days
Taurine lowered systolic blood pressure by about 4 mmHg, diastolic by about 1.5 mmHg, fasting glucose by about 5.9 mg/dL and triglycerides by about 18 mg/dL versus control; HDL cholesterol did not change. No significant adverse effects versus control.
- CGrade CBlood-sugar markers (HbA1c, fasting glucose, HOMA-IR) · Improved
Meta-analysis · n 209 · 2022 · Patients with diabetes in 5 randomized controlled trials
Varied across trials · Varied across trials
Taurine reduced HbA1c (SMD -0.41), fasting blood sugar and HOMA-IR in patients with diabetes, with no significant effect on serum lipids, blood pressure or body composition.